Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease

Climacteric

Volumn 17, Issue , 2014, Pages 38-46

  Henderson, V W ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Alzheimer's Disease; Cognitive Impairment; Cognitive Reserve; Midlife; Physical Activity; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID BETA PROTEIN; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; ESTROGEN;

AEROBIC EXERCISE; AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DEPRESSION; DIABETES MELLITUS; ESTROGEN THERAPY; EXERCISE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEISURE; MENOPAUSE; NONHUMAN; PREVENTION STUDY; RISK REDUCTION; SMOKING; STRATEGIC PLANNING; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; COGNITIVE RESERVE; COMPLICATION; FEMALE; LEARNING; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; RISK FACTOR;

ALZHEIMER DISEASE; CARDIOVASCULAR DISEASES; COGNITIVE RESERVE; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EXERCISE; FEMALE; HUMANS; LEARNING; MILD COGNITIVE IMPAIRMENT; RISK FACTORS;

EID: 84907863957     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.929650     Document Type: Conference Paper

References (108)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic revieWand metaanalysis. Alzheimers Dement 2013;9:63-75.e2
2. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nature Rev Neurol 2011;7:137-52
3. Alzheimer's Association. 2014 Alzheimer's disease facts and fi gures. Alzheimers Dement 2014;10:1-75
4. Kosik K S, Rapp P R, Raz N, Small S A, Sweatt J D, Tsai L H. Mechanisms of age-related cognitive change and targets for intervention: epigenetics. J Gerontol A Biol Sci Med Sci 2012;67:741-6
5. Craft S, Foster TC, Landfield PW, Maier SF, Resnick SM, Yaffe K. Mechanisms of age-related cognitive change and targets for intervention: infl ammatory, oxidative, and metabolic processes. J Gerontol A Biol Sci Med Sci 2012;67:754-9
6. Pavloppoulos E, Jones S, Kosmidis S, et al. Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med 2013;5:200ra115
7. Boyle P A, Wilson R S, Yu L, et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 2013;74:478-89
8. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262-70
9. Albert M S, Dekosky S T, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement 2011;7:270-9
10. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837-44
11. Henderson VW. Gonadal hormones and cognitive aging: a midlife perspective. Womens Health (Londengl) 2011;7:81-93
12. Guthrie J R, Dennerstein L, Taffe J R, Lehert P, Burger H G. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-89
13. McKinlay S M, Brambilla D J, Posner J G. The normal menopause transition. Maturitas 2008;61:4-16
14. Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition andearly postmenopause. Climacteric 2011;14:252-61
15. Ford N, Slade P, Butler G. An absence of evidence linking perceived memory problems to the menopause. Br J Gen Pract 2004;54:434-8
16. MT, Mapstone M, Staskiewicz J, Maki PM. Reconciling subjective memory complaints with objective memory performance in the menopausal transition. Menopause 2012;19:735-41
17. Salthouse T A. W hen does age-related cognitive decline begin?. Neurobiol Aging 2009;30:507-14
18. Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci 2010;21:187-221
19. Terry RD, Katzman R. Life span and synapses: will there be a primary senile dementia?. Neurobiol Aging 2001;22:347-8
20. Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause 2007;14:572-9
21. Rocca W A, Bower J H, Ahlskog J E, Grossardt B R, de Andrade M, Melton LJ, 3rd. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-83
22. Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause Influences cognitive decline and Alzheimer pathology in older women. Neurology 2014;82:222-9
23. Ryan J, Stanczyk FZ, Dennerstein L, et al. Hormone levels and cognitive function in postmenopausal midlife women. Neurobiol Aging 2012;33:1138-47
24. Henderson VW, St. John JA, Hodis HN, et al. Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Proc Natl Acad Sci U S A 2013;110:20290-5
25. Henderson VW, Popat RA. Effects of endogenous andexogenous estrogen exposures in midlife and late-life womeNon episodic memory andexecutive functions. Neuroscience 2011;191:129-38
26. Chen P, Ratcliff G, Belle S H, Cauley J A, Dekosky S T, Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001;58:853-8
27. Albert M S, Moss M B, Tanzi R, Jones K. P reclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc 2001;7:631-9
28. Asthana S, Gleason CE, Wharton W, et al. The Kronos Early Estrogen Prevention Study: Results of the Cognitive & Affective Sub-Study (KEEPS Cog). Menopause 2012;19:1364
29. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329-44
30. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960-9
31. Bateman R J, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804
32. Terry RD. Alzheimer's disease and the aging brain. J Geriatr Psychiatry Neurol 2006;19:125-8
33. Jellinger K A. Pathology and pathogenesis of vascular cognitive impairment-a criticaLupdate. Front Aging Neurosci 2013;5:17
34. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol 2011;70:774-80
35. Dolan D, Troncoso J, Resnick SM, Crain BJ, Zonderman AB, O'Brien RJ. Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain 2010;133:2225-31
36. Schneider J A, Arvanitakis Z, Bang W, Bennett D A. Mixed brain pathologies account for most dementia cases in communitydwellinGolder persons. Neurology 2007;69:2197-204
37. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales: Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-75
38. Stampfer MJ. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med 2006;260:211-23
39. Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, Obrien RJ. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol 2010;68:231-40
40. Launer L J, Petrovitch H, Ross GW, Markesbery W, White LR. AD brain pathology: vascular origins?. Results from the HAAS autopsy study. Neurobiol Aging 2008;29:1587-90
41. Bushnell C, McCullough L D, A wad I A, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545-88
42. Stern Y. Cognitive reserve in aging and Alzheimer's disease. Lancet Neurol 2012;11:1006-12
43. Sharp E S, Gatz M. Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord 2011;25:289-304
44. Potter GG, Helms MJ, Plassman BL. Associations of job demands and intelligence with cognitive performance among men in late life. Neurology 2008;70:1803-8
45. Stern C, Munn Z. Cognitive leisure activities and their role in preventing dementia: a systematic review. Int J Evid Based Healthc 2010;8:2-17
46. Karp A, Paillard-Borg S, Wang H X, Silverstein M, Winblad B, Fratiglioni L. Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord 2006;21:65-73
47. Fratiglioni L, Wang HX, Ericsson K, Mayton M, Winblad B. Influence of social network oNoccurrence of dementia: a community-based longitudinal study. Lancet 2000;344:1315-19
48. Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA. Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology 2013;81:314-21
49. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions witHolder adults: a randomized controlled trial. JAMA 2002;288:2271-81
50. Rebok G W, Ball K, Guey L T, et al. Ten-year effects of the advanced cognitive training for independenTand vital elderly cognitive training trial on cognition andeveryday functioning in older adults. J Am Geriatr Soc 2014;62:16-24
51. Martin M, Clare L, Altgassen AM, Cameron M H, Zehnder F. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Systematic Reviews 2011;1(CD006220
52. Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: a meta-analysis of prospective studies. J Intern Med 2011;269:107-17
53. Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimer's Disease and Cognitive Decline. Evidence Report/Technology Assessment Number 193. AHRQ Publication No. 10-E005. Rockville, MD: Department of Health and Human Services, 2010
54. Zhu N, Jacobs D R J r, Schreiner P J, et al. Cardiorespiratory fitness and cognitive function in middle age: The CARDIA Study. Neurology 2014;82:1339-46
55. Liu H L, Zhao G, Zhang H, Shi L D. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behav Brain Res 2013;256:261-72
56. Um HS, Kang EB, Leem YH, et al. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int J Mol Med 2008;22:529-39
57. Head D, Bugg J M, Goate A M, et al. Exercise engagement as a moderator of the effects of APOEgenotype on amyloid deposition. Arch Neurol 2012;69:636-43
58. Bretsky PM, Buckwalter JG, Seeman TE, et al. Evidence for an interaction between apolipoprotein Egenotype, gender, and Alzheimer disease. Alzheimer Dis Assoc Disord 1999;13:216-21
59. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, andethnicity on the association between apolipoprotein Egenotype and Alzheimer disease. JAMA 1997;278:1349-56
60. Altmann A, Tian L, Henderson VW, Greicius MD, ADNI Investigators. Sex modifi es the APOE-related risk of developing Alzheimer's disease. Ann Neurol 2014;75:563-73
61. Intlekofer KA, Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer's disease. Neurobiol Dis 2013;57:47-55
62. Erickson K I, Voss M W, Prakash R S, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 2011;108:3017-22
63. Korol D L, Gold P E, Scavuzzo C J. Use iTand boost it with physical and mental activity. Hippocampus 2013;32:125-35
64. Kobilo T, Liu QR, Gandhi K, Mughal M, Shaham Y, van Praag H. Running is the neurogenic and neurotrophic stimulus in environmental enrichment. Learn Mem 2011;18:605-9
65. Weinstein G, Beiser A S, Choi S H, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham heart study. JAMANeurol 2014;71:55-66
66. Pereira A C, Huddleston DE, Brickman A M, et al. An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA 2007;104:5638-43
67. Physical Activity Guidelines writing group. 2008 Physical Activity Guidelines for Americans. Washington, DC: US Department of Health and Human Services, 2008
68. Vest R S, Pike C J. Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav 2013;63:301-7
69. Bailey M E, Wang A C, Hao J, et al. Interactive effects of age andestrogeNon cortical neurons: implications for cognitive aging. Neuroscience 2011;191:148-58
70. McClure R E, Barha C K, Galea L A. 17 β-Estradiol, but not estrone, increases the survival and activation of new neurons in the hippocampus in response to spatial memory in adult female rats. Horm Behav 2013;63:144-57
71. Ding F, Yao J, Zhao L, Mao Z, Chen S, Brinton RD. Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's disease. PLoS One 2013;8:e59825
72. Shumaker SA, Legault C, Rapp SR, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS). JAMA 2003;289:2651-62
73. Shumaker SA, Legault C, Kuller L, et al. Conjugatedequine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2947-58
74. Henderson V W, Benke K S, Green R C, Cupples L A, Farrer LA. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005;76:103-5
75. Whitmer R A, Quesenberry C P, Zhou J, Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann Neurol 2011;69:163-9
76. Shao H, Breitner JCS, Whitmer RA, et al. Hormone therapy and AD dementia: new findings from the Cache County study. Neurology 2012;79:1846-52
77. Resnick S M, H enderson V W. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA 2002;288:2170-2
78. Hemminki E, Malin M, Topo P. Selection to postmenopausal therapy by women's characteristics. J Clin Epidemiol 1993;46:211-19
79. de Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 2013;16:316-37
80. North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257-71
81. Szekely C A, Green R C, Breitner J C, et al. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 2008;70:2291-8
82. Wong WB, Lin VW, Boudreau D, Devine EB. Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 2013;22:345-58
83. Jaturapatporn D, I saac M G, McCleery J, T abet N. A spirin, steroidal and non-steroidal anti-infl ammatory drugs for the treatment of Alzheimer's disease. Cochrane Database Systematic Rev 2012;15:CD006378
84. McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P. Statins for the treatment of dementia. Cochrane Database Systematic Rev 2010;8 :C D007514
85. McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Systematic Rev 2009;2 :c d003160
86. Thal LJ, Ferris SH, Kirby L, et al. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 2005;30:1204-15
87. ADAPT Research Group, Lyketsos CG, Breitner J C, et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007;68:1800-8
88. Alzheimer's Disease Anti-infl ammatory Prevention Trial Research Group. Results of a follow-up study to the randomized Alzheimer's Disease Anti-infl ammatory Prevention Trial (ADAPT). Alzheimers Dement 2013;9:714-23
89. Piazza-Gardner AK, Gaffud TJ, Barry AE. The impact of alcohol on Alzheimer's disease: a systematic review. Aging MenThealth 2013;17:133-46
90. Anstey K J, Mack H A, Cherbuin N. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 2009;17:542-55
91. Piazza-Gardner A K, B arry A E. Examining physical activity levels and alcohol consumption: are people who drink more active?. Am J Health Promot 2012;26:e95-e104
92. Au Yeung SL, Jiang CQ, Cheng KK, et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou biobank cohort study. Am J Epidemiol 2012;175:1021-8
93. Sabia S, Elbaz A, Britton A, et al. Alcohol consumption and cognitive decline in early old age. Neurology 2014;82:332-9
94. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293-9
95. Maki P M, Freeman E W, Greendale G A, et al. Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Menopause 2010;17:815-22
96. Ü chtemann D, Luppa M, Bramesfeld A, Riedel-Heller S. Incidence of late-life depression: a systematic review. J Affect Disord 2012;142:172-9
97. Ownby R L, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530-8
98. Diniz BS, Butters M A, Albert S M, Dew M A, Reynolds CFr. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic revieWand meta-analysis of community-based cohort studies. Br J Psychiatry 2013;202:329-35
99. Grinberg LT, R Ü b U, Ferretti RE, et al. The dorsal raphe nucleus shows phospho-tau neurofi brillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?. Neuropathol Appl Neurobiol 2009;35:406-16
100. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 2006;30:9047-56
101. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011;3:323-31
102. Singh B, Parsaik A K, Mielke M M, et al. A ssociation of mediterranean diet with mild cognitive impairmenTand Alzheimer's disease: a systematic revieWand meta-analysis. J Alzheimers Dis 2014;39:271-82
103. Martínez-Lapiscina E H, Clavero P, Toledo E, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry 2013;84:1318-25
104. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373-7
105. Huang Y, Potter R, Sigurdson W, et al. Effects of age and amyloid deposition on A βdynamics in the human central nervous system. Arch Neurol 2012;69:51-8
106. Spira A P, Gamaldo A A, An Y, et al. Self-reported sleep and β-amyloid deposition in community-dwellinGolder adults. JAMANeurol 2013;70:1537-43
107. Lim AS, Kowgier M, Yu L, Buchman AS, Bennett DA. Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 2013;36:1027-32
108. Ju Y E, Lucey B P, Holtzman D M. Sleep and Alzheimer disease pathology-a bidirectional relationship. Nat Rev Neurol 2014;10:115-19